Raymond James Financial
IDYA icon

Raymond James Financial’s IDEAYA Biosciences IDYA Stock Holding History

Raymond James Financial’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-34
Closed -$715 – 5787
2025
Q2 		$715 Buy
+34
New +$652 ﹤0.01% 6620
2025
Q1 		– Sell
-16,769
Closed -$431K – 4881
2024
Q4 		$431K Buy
+16,769
New +$475K ﹤0.01% 3991

Other funds holding IDYA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Raymond James Financial's IDYA Position: Q3 2025 in Review

Raymond James Financial sold out of IDEAYA Biosciences (IDYA) in Q3 2025, closing a stake of 34 shares — an estimated $715 sold.

Raymond James Financial first reported a position in IDYA in Q4 2024 and held it in 2 quarters. The position peaked at $431K in Q4 2024. 224 funds tracked by Wall St. Rank hold IDYA as of Q3 2025.

  • Raymond James Financial reported no remaining IDEAYA Biosciences position as of Q3 2025 after selling out during the quarter.
  • Raymond James Financial sold 34 IDEAYA Biosciences shares in Q3 2025, an estimated $715.
  • Raymond James Financial first reported a position in IDEAYA Biosciences in Q4 2024 and held it in 2 quarters.
  • Raymond James Financial's IDEAYA Biosciences position peaked at $431K in Q4 2024.
  • 224 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q3 2025.

Based on Raymond James Financial's 13F filing for Q3 2025, filed 14 Nov 2025.